# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-22-016378
Filing Date
2022-09-26
Accepted
2022-09-26 09:07:37
Documents
4
Period of Report
2022-09-26

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | dp181091_6k.htm | 6-K | 12005
2 | EXHIBIT 99.1 | dp181091_ex9901.htm | EX-99.1 | 22071
3 | GRAPHIC | image_001.jpg | GRAPHIC | 684056
4 | GRAPHIC | image_002.jpg | GRAPHIC | 53376
| Complete submission text file | 0000950103-22-016378.txt |  | 1041036

Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 221263688
SIC: 2834 Pharmaceutical Preparations